XYLOCOR THERAPEUTICS
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patients with refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
XYLOCOR THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Address:
Wayne, Pennsylvania, United States
Country:
United States
Website Url:
http://www.xylocor.com
Total Employee:
1+
Status:
Active
Contact:
888-290-0081
Email Addresses:
[email protected]
Total Funding:
39.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Apache ReCAPTCHA JsDelivr AJAX Libraries API ReCAPTCHA V2 CPanel SSL
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Current Advisors List
Current Employees Featured
Founder
Investors List
Longwood Fund
Longwood Fund investment in Series A - XyloCor Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Series A - XyloCor Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series A - XyloCor Therapeutics
Lumira Ventures
Lumira Ventures investment in Series A - XyloCor Therapeutics
Fountain Healthcare Partners
Fountain Healthcare Partners investment in Series A - XyloCor Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Series A - XyloCor Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series A - XyloCor Therapeutics
Official Site Inspections
http://www.xylocor.com
- Host name: 69.174.115.195
- IP address: 69.174.115.195
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
